Free Trial

Marpai (MRAI) Competitors

Marpai logo
$1.18 -0.13 (-9.92%)
As of 08/1/2025 03:57 PM Eastern

MRAI vs. QIPT, CORBF, NAKA, KDLY, ATPC, BNR, BDSX, PIII, OPGN, and BMGL

Should you be buying Marpai stock or one of its competitors? The main competitors of Marpai include Quipt Home Medical (QIPT), Global Cord Blood (CORBF), KindlyMD (NAKA), Kindly MD (KDLY), Agape ATP (ATPC), Burning Rock Biotech (BNR), Biodesix (BDSX), P3 Health Partners (PIII), OpGen (OPGN), and Basel Medical Group (BMGL). These companies are all part of the "healthcare" industry.

Marpai vs. Its Competitors

Marpai (NASDAQ:MRAI) and Quipt Home Medical (NASDAQ:QIPT) are both small-cap healthcare companies, but which is the better business? We will compare the two companies based on the strength of their dividends, profitability, valuation, institutional ownership, risk, earnings, media sentiment and analyst recommendations.

Quipt Home Medical has a net margin of -3.66% compared to Marpai's net margin of -85.70%. Marpai's return on equity of 0.00% beat Quipt Home Medical's return on equity.

Company Net Margins Return on Equity Return on Assets
Marpai-85.70% N/A -100.23%
Quipt Home Medical -3.66%-8.38%-3.63%

In the previous week, Quipt Home Medical had 4 more articles in the media than Marpai. MarketBeat recorded 4 mentions for Quipt Home Medical and 0 mentions for Marpai. Quipt Home Medical's average media sentiment score of 0.35 beat Marpai's score of 0.00 indicating that Quipt Home Medical is being referred to more favorably in the news media.

Company Overall Sentiment
Marpai Neutral
Quipt Home Medical Neutral

49.8% of Marpai shares are held by institutional investors. Comparatively, 42.9% of Quipt Home Medical shares are held by institutional investors. 46.1% of Marpai shares are held by insiders. Comparatively, 13.4% of Quipt Home Medical shares are held by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock will outperform the market over the long term.

Quipt Home Medical has higher revenue and earnings than Marpai. Quipt Home Medical is trading at a lower price-to-earnings ratio than Marpai, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Marpai$34.87M0.56-$28.75M-$1.82-0.65
Quipt Home Medical$245.91M0.41-$6.76M-$0.21-11.00

Quipt Home Medical has a consensus target price of $2.85, suggesting a potential upside of 23.38%. Given Quipt Home Medical's stronger consensus rating and higher probable upside, analysts clearly believe Quipt Home Medical is more favorable than Marpai.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Marpai
0 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
0.00
Quipt Home Medical
0 Sell rating(s)
1 Hold rating(s)
1 Buy rating(s)
0 Strong Buy rating(s)
2.50

Marpai has a beta of 4.66, suggesting that its share price is 366% more volatile than the S&P 500. Comparatively, Quipt Home Medical has a beta of 0.59, suggesting that its share price is 41% less volatile than the S&P 500.

Summary

Quipt Home Medical beats Marpai on 10 of the 16 factors compared between the two stocks.

Get Marpai News Delivered to You Automatically

Sign up to receive the latest news and ratings for MRAI and its competitors with MarketBeat's FREE daily newsletter.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding MRAI and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

MRAI vs. The Competition

MetricMarpaihealth & allied services, not elsewhere classified IndustryBusiness SectorNASDAQ Exchange
Market Cap$19.51M$64.04M$14.76B$9.37B
Dividend YieldN/AN/A2.86%4.12%
P/E Ratio-0.450.5521.2022.29
Price / Sales0.560.3640.7596.30
Price / CashN/A2.8026.1157.18
Price / Book-0.690.115.085.54
Net Income-$28.75M$43.11M$196.77M$259.88M
7 Day Performance-9.92%-3.31%-4.30%-4.66%
1 Month Performance-14.49%-39.40%-1.16%4.40%
1 Year Performance126.88%7.18%28.86%17.92%

Marpai Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
MRAI
Marpai
N/A$1.18
-9.9%
N/A+122.6%$19.51M$34.87M-0.45150Upcoming Earnings
Gap Down
QIPT
Quipt Home Medical
2.0178 of 5 stars
$2.21
+9.4%
$2.85
+29.0%
-39.5%$87.76M$245.91M-10.521,200
CORBF
Global Cord Blood
N/A$0.55
-0.1%
N/AN/A$66.85M$196.12M0.001,200Gap Up
NAKA
KindlyMD
N/A$11.17
+2.0%
N/AN/A$66.03M$2.72M-14.51N/AGap Down
KDLY
Kindly MD
N/A$10.95
-0.6%
N/A+332.3%$65.94M$2.47M-14.22N/AGap Down
ATPC
Agape ATP
0.2756 of 5 stars
$1.35
+3.8%
N/A-57.4%$65.01M$1.32M-2.2540News Coverage
BNR
Burning Rock Biotech
0.7798 of 5 stars
$5.83
+16.8%
N/A-17.0%$53.73M$523.28M-3.081,390
BDSX
Biodesix
3.5539 of 5 stars
$0.36
+2.9%
$1.75
+386.1%
-77.7%$51.30M$71.32M-1.24220News Coverage
Upcoming Earnings
PIII
P3 Health Partners
2.1766 of 5 stars
$7.44
+11.9%
$16.25
+118.4%
-75.9%$47.80M$1.50B-0.16500News Coverage
Gap Down
OPGN
OpGen
N/A$4.70
flat
N/A-98.7%$47.32M$2.67M0.00100Short Interest ↓
BMGL
Basel Medical Group
N/A$2.20
-6.0%
N/AN/A$43.19MN/A0.0036Gap Down

Related Companies and Tools


This page (NASDAQ:MRAI) was last updated on 8/2/2025 by MarketBeat.com Staff
From Our Partners